Margaret R. Spitz

Margaret R. Spitz's AcademicInfluence.com Rankings

Margaret R. Spitz

Medical

#1702

World Rank

#2069

Historical Rank

Oncology

#84

World Rank

#88

Historical Rank

Epidemiology

#268

World Rank

#285

Historical Rank

medical Degrees

Margaret R. Spitz

Philosophy

#5138

World Rank

#7867

Historical Rank

Logic

#2467

World Rank

#3463

Historical Rank

philosophy Degrees

Download Badge

Medical
Philosophy

Margaret R. Spitz's Degrees

Doctorate Medicine University of Texas Medical Branch

Why Is Margaret R. Spitz Influential?

(Suggest an Edit or Addition)

(See a Problem?)

Margaret R. Spitz's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

Somatic mutations affect key pathways in lung adenocarcinoma (2008) (2640)
Genome-wide association scan of tag SNPs identifies a susceptibility locus for lung cancer at 15q25.1 (2008) (1262)
Characterizing the cancer genome in lung adenocarcinoma (2007) (1122)
Plasma levels of insulin-like growth factor-I and lung cancer risk: a case-control analysis. (1999) (581)
Common 5p15.33 and 6p21.33 variants influence lung cancer risk (2008) (550)
A genome-wide association study of lung cancer identifies a region of chromosome 5p15 associated with risk for adenocarcinoma. (2009) (532)
The PhenX Toolkit: Get the Most From Your Measures (2011) (520)
Repair of tobacco carcinogen-induced DNA adducts and lung cancer risk: a molecular epidemiologic study. (2000) (520)
Modulation of nucleotide excision repair capacity by XPD polymorphisms in lung cancer patients. (2001) (519)
Detectable clonal mosaicism and its relationship to aging and cancer (2012) (512)
Telomere dysfunction: a potential cancer predisposition factor. (2003) (487)
Multiple Independent Loci at Chromosome 15q25.1 Affect Smoking Quantity: a Meta-Analysis and Comparison with Lung Cancer and COPD (2010) (400)
A risk model for prediction of lung cancer. (2007) (389)
Ethnic differences in the prevalence of the homozygous deleted genotype of glutathione S-transferase theta. (1995) (374)
Genetic susceptibility to lung cancer: the role of DNA damage and repair. (2003) (359)
Large-scale association analysis identifies new lung cancer susceptibility loci and heterogeneity in genetic susceptibility across histological subtypes (2017) (353)
Shifting paradigm of association studies: value of rare single-nucleotide polymorphisms. (2008) (349)
Polymorphisms of DNA repair gene XRCC1 in squamous cell carcinoma of the head and neck. (1999) (332)
Rare variants of large effect in BRCA2 and CHEK2 affect risk of lung cancer (2014) (322)
The landscape of recombination in African Americans (2011) (312)
Reduced DNA repair capacity in lung cancer patients. (1996) (310)
Marijuana use and increased risk of squamous cell carcinoma of the head and neck. (1999) (300)
Bladder cancer predisposition: a multigenic approach to DNA-repair and cell-cycle-control genes. (2006) (278)
Progress in Chemoprevention Drug Development: The Promise of Molecular Biomarkers for Prevention of Intraepithelial Neoplasia and Cancer—A Plan to Move Forward (2006) (272)
Modulation of repair of ultraviolet damage in the host-cell reactivation assay by polymorphic XPC and XPD/ERCC2 genotypes. (2002) (270)
Multiple primary cancer in patients with cancer of the head and neck: second cancer of the head and neck, esophagus, and lung. (1989) (267)
p53 Genotypes and Haplotypes Associated With Lung Cancer Susceptibility and Ethnicity. (2002) (261)
Dietary intake of isothiocyanates: evidence of a joint effect with glutathione S-transferase polymorphisms in lung cancer risk. (2000) (257)
Deciphering the impact of common genetic variation on lung cancer risk: a genome-wide association study. (2009) (244)
Case-control study of the D2 dopamine receptor gene and smoking status in lung cancer patients. (1998) (244)
A Meta-Analysis Identifies New Loci Associated with Body Mass index in Individuals of African Ancestry (2013) (244)
Mitochondrial DNA content: its genetic heritability and association with renal cell carcinoma. (2008) (240)
The CHRNA5-A3 region on chromosome 15q24-25.1 is a risk factor both for nicotine dependence and for lung cancer. (2008) (238)
Phytoestrogen intake and prostate cancer: a case-control study using a new database. (1999) (234)
A single nucleotide polymorphism in the matrix metalloproteinase-1 promoter enhances lung cancer susceptibility. (2001) (232)
Familial patterns of prostate cancer: a case-control analysis. (1991) (227)
Genetic variants and risk of lung cancer in never smokers: a genome-wide association study. (2010) (224)
Polymorphisms of the DNA repair gene XRCC1 and risk of gastric cancer in a Chinese population (2000) (223)
Descriptive epidemiology and risk factors for head and neck cancer. (2004) (220)
From genotype to phenotype: correlating XRCC1 polymorphisms with mutagen sensitivity. (2003) (207)
XPD/ERCC2 polymorphisms and risk of head and neck cancer: a case-control analysis. (2000) (205)
Ethnic variation in the prevalence of a common NAD(P)H quinone oxidoreductase polymorphism and its implications for anti-cancer chemotherapy. (1997) (204)
A novel polymorphism in human cytosine DNA-methyltransferase-3B promoter is associated with an increased risk of lung cancer. (2002) (200)
Reduced DNA repair capacity in head and neck cancer patients. (1998) (199)
Replication of lung cancer susceptibility loci at chromosomes 15q25, 5p15, and 6p21: a pooled analysis from the International Lung Cancer Consortium. (2010) (198)
Influence of common genetic variation on lung cancer risk: meta-analysis of 14 900 cases and 29 485 controls (2012) (196)
Birthplace, Years of Residence in the United States, and Obesity Among Mexican‐American Adults (2007) (187)
Effects of nativity, age at migration, and acculturation on smoking among adult Houston residents of Mexican descent. (2005) (185)
XPA polymorphism associated with reduced lung cancer risk and a modulating effect on nucleotide excision repair capacity. (2003) (182)
Chromosome sensitivity to bleomycin-induced mutagenesis, an independent risk factor for upper aerodigestive tract cancers. (1989) (181)
Assessing the function of genetic variants in candidate gene association studies (2004) (180)
An analysis of DNA repair as a determinant of survival in patients with non-small-cell lung cancer. (2002) (178)
Epidemiology and risk factors for head and neck cancer. (1994) (176)
Lung carcinoma in former smokers (1996) (176)
Rapid assessment of repair of ultraviolet DNA damage with a modified host-cell reactivation assay using a luciferase reporter gene and correlation with polymorphisms of DNA repair genes in normal human lymphocytes. (2002) (174)
Relationship between CYP2A6 and CHRNA5-CHRNA3-CHRNB4 variation and smoking behaviors and lung cancer risk. (2011) (170)
Cytokinesis-blocked micronucleus assay as a novel biomarker for lung cancer risk. (2006) (169)
Leptin and prostate cancer (2001) (166)
Human papillomavirus type 16 infection and squamous cell carcinoma of the head and neck in never-smokers: a matched pair analysis. (2003) (158)
Higher lung cancer risk for younger African-Americans with the Pro/Pro p53 genotype. (1995) (158)
Familial aggregation of common sequence variants on 15q24-25.1 in lung cancer. (2008) (157)
p53 mutations in nonmelanoma skin cancer of the head and neck: molecular evidence for field cancerization. (1995) (157)
Second primary tumors in patients with upper aerodigestive tract cancers: joint effects of smoking and alcohol (United States) (2003) (152)
An Expanded Risk Prediction Model for Lung Cancer (2008) (148)
Mutagen sensitivity in patients with head and neck cancers: a biologic marker for risk of multiple primary malignancies. (1990) (147)
Smoking affects treatment outcome in patients with advanced nonsmall cell lung cancer (2006) (146)
Meta- and pooled analysis of GSTT1 and lung cancer: a HuGE-GSEC review. (2006) (145)
Polymorphisms of 5,10‐methylenetetrahydrofolate reductase and risk of gastric cancer in a Chinese population: A case‐control study (2001) (144)
Repair of UV light-induced DNA damage and risk of cutaneous malignant melanoma. (2003) (144)
Association between hypothyroidism and hepatocellular carcinoma: A case‐control study in the United States (2009) (144)
Associations between cytochrome P4502E1 genotype, mutagen sensitivity, cigarette smoking and susceptibility to lung cancer. (1997) (144)
Smoking, DNA repair capacity and risk of nonsmall cell lung cancer (2003) (141)
Reduced expression levels of nucleotide excision repair genes in lung cancer: a case-control analysis. (2000) (141)
Increased risk of lung cancer in individuals with a family history of the disease: a pooled analysis from the International Lung Cancer Consortium. (2012) (140)
Cyclin D1 polymorphism and risk for squamous cell carcinoma of the head and neck: a case-control study. (2001) (140)
Polymorphisms, Mutations, and Amplification of the EGFR Gene in Non-Small Cell Lung Cancers (2007) (139)
Systematic evaluation of genetic variants in the inflammation pathway and risk of lung cancer. (2007) (137)
Genetic variants on 15q25.1, smoking, and lung cancer: an assessment of mediation and interaction. (2012) (137)
Hormone Replacement Therapy and Lung Cancer Risk (2004) (135)
Case-control study of diet and prostate cancer in China (1998) (135)
An intronic poly (AT) polymorphism of the DNA repair gene XPC and risk of squamous cell carcinoma of the head and neck: a case-control study. (2001) (133)
Major salivary gland carcinoma. Descriptive epidemiology and survival of 498 patients. (1984) (132)
Alterations of p53, cyclin D1, rb, and H‐ras in human oral carcinomas related to tobacco use (1998) (128)
Glutathione s-transferase genotypes as risk factors for head and neck cancer. (1995) (127)
Plasma levels of insulin-like growth factor-1 and binding protein-3, and their association with bladder cancer risk. (2003) (126)
Expression of nucleotide excision repair genes and the risk for squamous cell carcinoma of the head and neck (2002) (125)
Longitudinal study of smoking patterns in relation to the development of smoking‐related secondary primary tumors in patients with upper aerodigestive tract malignancies (2004) (124)
Neuroblastoma and paternal occupation. A case-control analysis. (1985) (123)
Analysis of human papillomavirus DNA in oral squamous cell carcinomas. (1993) (121)
Lung cancer in Mexican-Americans and African-Americans is associated with the wild-type genotype of the NAD(P)H: quinone oxidoreductase polymorphism. (1997) (121)
A Review of the Application of Inflammatory Biomarkers in Epidemiologic Cancer Research (2014) (121)
P53 codon 72 polymorphism and risk of squamous cell carcinoma of the head and neck: a case-control study. (2002) (120)
Cancer and age. (1989) (120)
The development of breast carcinoma in women with thyroid carcinoma (2001) (120)
Genetic susceptibility to head and neck squamous cell carcinoma. (1996) (118)
Mutagen sensitivity as a risk factor for second malignant tumors following malignancies of the upper aerodigestive tract. (1994) (118)
Benzo(a)pyrene diol epoxide-induced chromosomal aberrations and risk of lung cancer. (1996) (117)
Glutathione‐S‐transferase polymorphisms and risk of squamous‐cell carcinoma of the head and neck (1999) (117)
Transforming Epidemiology for 21st Century Medicine and Public Health (2013) (116)
Molecular epidemiology and retinoid chemoprevention of head and neck cancer. (1997) (115)
An Evolutionary Perspective on Single-Nucleotide Polymorphism Screening in Molecular Cancer Epidemiology (2004) (115)
Clinicopathologic Characteristics of the EGFR Gene Mutation in Non–small Cell Lung Cancer (2006) (114)
DNA repair gene ERCC1 and ERCC2/XPD polymorphisms and risk of squamous cell carcinoma of the head and neck. (2002) (114)
Genetic susceptibility to cancer: ICRP Publication 79 (1993) (113)
Mutagen sensitivity in upper aerodigestive tract cancer: a case-control analysis. (1993) (111)
International Lung Cancer Consortium: Pooled Analysis of Sequence Variants in DNA Repair and Cell Cycle Pathways (2008) (110)
Susceptibility to lung cancer in light smokers associated with CYP1A1 polymorphisms in Mexican- and African-Americans. (1997) (109)
Squamous cell carcinoma of the upper aerodigestive tract. A case comparison analysis (1988) (109)
Dietary phytoestrogens and lung cancer risk. (2005) (107)
Mutagen sensitivity as a biological marker of lung cancer risk in African Americans. (1995) (107)
Is there a genetic basis for lung cancer susceptibility? (1999) (106)
Molecular epidemiology, cancer-related symptoms, and cytokines pathway. (2008) (101)
Identifying and recruiting healthy control subjects from a managed care organization: a methodology for molecular epidemiological case-control studies of cancer. (1997) (101)
Body mass index and risk of lung cancer among never, former, and current smokers. (2012) (100)
Development and Validation of a Lung Cancer Risk Prediction Model for African-Americans (2008) (100)
Mutagen sensitivity: a biological marker of cancer susceptibility. (1991) (99)
Never smokers and lung cancer risk: A case‐control study of epidemiological factors (2006) (98)
Sulfotransferase (SULT) 1A1 polymorphism as a predisposition factor for lung cancer: a case-control analysis. (2002) (96)
Association of a p73 exon 2 G4C14-to-A4T14 polymorphism with risk of squamous cell carcinoma of the head and neck. (2004) (96)
Evolutionary evidence of the effect of rare variants on disease etiology (2011) (96)
Genetic variants of myeloperoxidase and lung cancer risk. (2000) (95)
Environmental tobacco smoking, mutagen sensitivity, and head and neck squamous cell carcinoma. (2000) (94)
A myeloperoxidase polymorphism associated with reduced risk of lung cancer. (2002) (93)
Genetic instability in bladder cancer assessed by the comet assay. (2003) (93)
Dietary boron and hormone replacement therapy as risk factors for lung cancer in women. (2007) (92)
Polymorphisms of folate metabolic genes and susceptibility to bladder cancer: a case-control study. (2004) (92)
Characterization of large structural genetic mosaicism in human autosomes. (2015) (91)
Genetic Variants in Inflammation-Related Genes Are Associated with Radiation-Induced Toxicity Following Treatment for Non-Small Cell Lung Cancer (2010) (91)
Effects of smoking and radiotherapy on lung carcinoma in breast carcinoma survivors (2003) (89)
Association between low dietary folate intake and suboptimal cellular DNA repair capacity. (2003) (88)
Imputation and subset-based association analysis across different cancer types identifies multiple independent risk loci in the TERT-CLPTM1L region on chromosome 5p15.33. (2014) (88)
An association between NQO1 genetic polymorphism and risk of bladder cancer. (2003) (86)
Genome-wide association study of survival in non-small cell lung cancer patients receiving platinum-based chemotherapy. (2011) (86)
Polymorphisms of methylene-tetrahydrofolate reductase and risk of lung cancer: a case-control study. (2001) (85)
Sex Differences in Risk of Lung Cancer Associated with Methylene-tetrahydrofolate Reductase Polymorphisms (2005) (84)
Association between glutathione S-transferase p1 polymorphisms and lung cancer risk in Caucasians: a case-control study. (2003) (84)
Sensitivity to benzo(a)pyrene diol-epoxide associated with risk of breast cancer in young women and modulation by glutathione S-transferase polymorphisms: a case-control study. (2001) (82)
Adenocarcinoma of the lung in young patients (2000) (82)
Risk factors for major salivary gland carcinoma. A case‐comparison study (1984) (81)
Increased genetic vulnerability to smoking at CHRNA5 in early-onset smokers. (2012) (81)
Aggregation of cancer among relatives of never‐smoking lung cancer patients (2007) (80)
Effect of different types of smoking and synergism with hepatitis C virus on risk of hepatocellular carcinoma in American men and women: Case‐control study (2008) (80)
Molecular epidemiologic studies within the Selenium and Vitamin E Cancer Prevention Trial (SELECT) (2004) (80)
In vitro induction of benzo(a)pyrene diol epoxide-DNA adducts in peripheral lymphocytes as a susceptibility marker for human lung cancer. (1996) (80)
Genetic polymorphisms in DNA base‐excision repair genes ADPRT, XRCC1, and APE1 and the risk of squamous cell carcinoma of the head and neck (2007) (79)
Risk for smoking-related cancer among relatives of lung cancer patients. (2003) (79)
Serum insulin-like growth factor (IGF) and IGF-binding protein levels and risk of lung cancer: a case-control study nested in the beta-Carotene and Retinol Efficacy Trial Cohort. (2002) (78)
Polymorphisms of FAS and FAS Ligand Genes Involved in the Death Pathway and Risk and Progression of Squamous Cell Carcinoma of the Head and Neck (2006) (78)
Genetic Variants in Cell Cycle Control Pathway Confer Susceptibility to Lung Cancer (2007) (78)
IARC Monographs: 40 Years of Evaluating Carcinogenic Hazards to Humans (2015) (78)
Genetic polymorphisms of p21 are associated with risk of squamous cell carcinoma of the head and neck. (2005) (78)
Meta-analysis and pooled analysis of GSTM1 and CYP1A1 polymorphisms and oral and pharyngeal cancers: a HuGE-GSEC review (2008) (78)
Joint effect of insulin-like growth factors and mutagen sensitivity in lung cancer risk. (2000) (77)
Smoking and Genetic Risk Variation Across Populations of European, Asian, and African American Ancestry—A Meta‐Analysis of Chromosome 15q25 (2012) (77)
Mediating effects of smoking and chronic obstructive pulmonary disease on the relation between the CHRNA5‐A3 genetic locus and lung cancer risk (2010) (76)
Nicotinic acetylcholine receptor region on chromosome 15q25 and lung cancer risk among African Americans: a case-control study. (2010) (76)
Cytokinesis-Blocked Micronucleus Cytome Assay Biomarkers Identify Lung Cancer Cases Amongst Smokers (2008) (76)
Wood dust exposure and the association with lung cancer risk. (2005) (75)
Cytochrome P450 2E1 DraI polymorphisms in lung cancer in minority populations. (1998) (75)
Aberrant Promoter Methylation Profile and Association with Survival in Patients with Non–Small Cell Lung Cancer (2006) (74)
Opposing effects of emphysema, hay fever, and select genetic variants on lung cancer risk. (2005) (74)
Mutagen sensitivity: a genetic predisposition factor for cancer. (2007) (74)
CHRNA5 risk variant predicts delayed smoking cessation and earlier lung cancer diagnosis--a meta-analysis. (2015) (74)
A case-control study of wood dust exposure, mutagen sensitivity, and lung cancer risk. (1995) (73)
Sensitivity to DNA damage induced by benzo(a)pyrene diol epoxide and risk of lung cancer: a case-control analysis. (2001) (73)
Polymorphisms in the glutathione S-transferase class mu and theta genes interact and increase susceptibility to lung cancer in minority populations (Texas, United States) (1997) (73)
Comparison of discriminatory power and accuracy of three lung cancer risk models (2010) (73)
Dietary zinc, copper and selenium, and risk of lung cancer (2006) (72)
Childhood nervous system tumours: an assessment of risk associated with paternal occupations involving use, repair or manufacture of electrical and electronic equipment. (1989) (72)
Female chromosome X mosaicism is age-related and preferentially affects the inactivated X chromosome (2016) (72)
Variant alleles of the D2 dopamine receptor gene and obesity (2000) (72)
Mutagen sensitivity has high heritability: evidence from a twin study. (2006) (72)
Plasma concentrations of insulin-like growth factors among healthy adult men and postmenopausal women: associations with body composition, lifestyle, and reproductive factors. (2002) (72)
Serum Levels of Insulin Growth Factor (IGF-I) and IGF-Binding Protein Predict Risk of Second Primary Tumors in Patients with Head and Neck Cancer (2004) (71)
Genetic variation in the PNPLA3 gene and hepatocellular carcinoma in USA: Risk and prognosis prediction (2013) (71)
Polymorphisms of Methionine Synthase and Methionine Synthase Reductase and Risk of Squamous Cell Carcinoma of the Head and Neck: a Case-Control Analysis (2005) (71)
Reproductive and Hormonal Factors and Lung Cancer Risk in the NIH-AARP Diet and Health Study Cohort (2011) (70)
Ethnic patterns of thyroid cancer incidence in the United States, 1973‐1981 (1988) (70)
MDM2 gene promoter polymorphisms and risk of lung cancer: a case-control analysis. (2006) (70)
A parallel study of in vitro sensitivity to benzo[a]pyrene diol epoxide and bleomycin in lung carcinoma cases and controls (1998) (69)
Reduced expression of hMLH1 and hGTBP/hMSH6: a risk factor for head and neck cancer. (1998) (69)
DNA repair capacity correlates with mutagen sensitivity in lymphoblastoid cell lines. (1996) (69)
Risk factor analysis among men referred for possible acquired immune deficiency syndrome. (1985) (68)
Projecting individualized probabilities of developing bladder cancer in white individuals. (2007) (68)
Cytokine Genes and Pain Severity in Lung Cancer: Exploring the Influence of TNF-α-308 G/A IL6-174G/C and IL8-251T/A (2007) (67)
Expression of Telomere-Associated Genes as Prognostic Markers for Overall Survival in Patients with Non–Small Cell Lung Cancer (2006) (66)
PI3K/PTEN/AKT/mTOR pathway genetic variation predicts toxicity and distant progression in lung cancer patients receiving platinum-based chemotherapy. (2011) (66)
Nucleotide Excision Repair Pathway Genes and Oral Premalignant Lesions (2007) (65)
Limiting the location of putative human prostate cancer tumor suppressor genes on chromosome 18q (1999) (65)
p73 G4C14-to-A4T14 Polymorphism and Risk of Lung Cancer (2004) (65)
Correlates of susceptibility to smoking among Mexican origin youth residing in Houston, Texas: A cross-sectional analysis (2008) (65)
Association between glutathione S‐transferase π polymorphisms and survival in patients with advanced nonsmall cell lung carcinoma (2006) (65)
Novel genetic variants in the chromosome 5p15.33 region associate with lung cancer risk. (2011) (65)
Maternal BMI and Country of Birth as Indicators of Childhood Obesity in Children of Mexican Origin (2007) (65)
Dietary folate intake and lung cancer risk in former smokers: a case-control analysis. (2003) (64)
Benzo[a]pyrene diol epoxide and bleomycin sensitivity and susceptibility to cancer of upper aerodigestive tract. (1998) (64)
In vitro sensitivity to ultraviolet B light and skin cancer risk: a case-control analysis. (2005) (64)
Salivary gland cancer. A case-control investigation of risk factors. (1990) (64)
Chromosome instability in lymphocytes: a potential indicator of predisposition to oral premalignant lesions. (2002) (64)
Analysis of aromatic DNA adducts and 7,8‐dihydro‐8‐oxo‐ 2′‐deoxyguanosine in lymphocyte DNA from a case–control study of lung cancer involving minority populations (2000) (63)
Fas A670G polymorphism, apoptotic capacity in lymphocyte cultures, and risk of lung cancer. (2003) (63)
Role of Inflammation Gene Polymorphisms on Pain Severity in Lung Cancer Patients (2009) (63)
Incidence and descriptive features of testicular cancer among United States whites, blacks, and hispanics, 1973–1982 (1986) (62)
Novel Susceptibility Loci for Second Primary Tumors/Recurrence in Head and Neck Cancer Patients: Large-Scale Evaluation of Genetic Variants (2009) (62)
Potentially Functional Single Nucleotide Polymorphisms in the Core Nucleotide Excision Repair Genes and Risk of Squamous Cell Carcinoma of the Head and Neck (2007) (62)
D2 dopamine receptor gene polymorphisms among African-Americans and Mexican-Americans: a lung cancer case-control study. (2000) (62)
Correlation between selected environmental exposures and karyotype in acute myelocytic leukemia. (1996) (62)
A variant of the DNA repair gene XRCC3 and risk of squamous cell carcinoma of the head and neck: A case‐control analysis (2002) (62)
International Lung Cancer Consortium: coordinated association study of 10 potential lung cancer susceptibility variants. (2010) (62)
Correlates of mutagen sensitivity in patients with upper aerodigestive tract cancer. (1997) (62)
Roles of genetic variants in the PI3K and RAS/RAF pathways in susceptibility to endometrial cancer and clinical outcomes (2012) (61)
Prognostic significance of ataxia‐telangiectasia mutated, DNA‐dependent protein kinase catalytic subunit, and Ku heterodimeric regulatory complex 86‐kD subunit expression in patients with nonsmall cell lung cancer (2008) (61)
Childhood nervous system tumors--an evaluation of the association with paternal occupational exposure to hydrocarbons. (1987) (61)
Genome-wide scan of 29,141 African Americans finds no evidence of directional selection since admixture. (2014) (60)
MicroRNA-related genetic variations as predictors for risk of second primary tumor and/or recurrence in patients with early-stage head and neck cancer. (2010) (59)
Genetic variations in interleukin-8 and interleukin-10 are associated with pain, depressed mood, and fatigue in lung cancer patients. (2013) (59)
The role of DNA repair capacity in susceptibility to lung cancer: A review (1997) (59)
Mutagen sensitivity to benzo(a)pyrene diol epoxide and the risk of squamous cell carcinoma of the head and neck. (1998) (58)
Methylenetetrahydrofolate reductase polymorphisms and risk of squamous cell carcinoma of the head and neck: A case‐control analysis (2005) (58)
Cyclin D1 gene polymorphism as a risk factor for oral premalignant lesions. (2006) (58)
DNA repair gene XRCC3 241Met variant is not associated with risk of cutaneous malignant melanoma. (2002) (58)
DNA repair capacity in peripheral lymphocytes predicts survival of patients with non-small-cell lung cancer treated with first-line platinum-based chemotherapy. (2011) (58)
Cross Cancer Genomic Investigation of Inflammation Pathway for Five Common Cancers: Lung, Ovary, Prostate, Breast, and Colorectal Cancer. (2015) (57)
Lung tissue microbial profile in lung cancer is distinct from emphysema. (2018) (57)
A race-specific genetic polymorphism in the CYP1A1 gene is not associated with lung cancer in African Americans. (1994) (57)
Case-control analysis of thymidylate synthase polymorphisms and risk of lung cancer. (2004) (57)
Volatile nitrites. Use and adverse effects related to the current epidemic of the acquired immune deficiency syndrome. (1985) (57)
Inherited variation at chromosome 12p13.33, including RAD52, influences the risk of squamous cell lung carcinoma. (2012) (56)
Thymidylate Synthase 5′- and 3′-Untranslated Region Polymorphisms Associated with Risk and Progression of Squamous Cell Carcinoma of the Head and Neck (2004) (56)
Research methodology: Strengthening causal interpretations of nonexperimental data (2004) (56)
Lung cancer chemoprevention: an integrated approach. (2001) (56)
Polymorphisms of vitamin D receptor gene protect against the risk of head and neck cancer (2005) (56)
Polymorphisms of methionine synthase and methionine synthase reductase and risk of lung cancer: a case–control analysis (2005) (56)
Association between asbestos exposure, cigarette smoking, myeloperoxidase (MPO) genotypes, and lung cancer risk. (2002) (55)
Dietary magnesium and DNA repair capacity as risk factors for lung cancer. (2008) (55)
p53 codon 72 Arg homozygotes are associated with an increased risk of cutaneous melanoma. (2003) (55)
Alcohol dehydrogenase 3 genotype is not associated with risk of squamous cell carcinoma of the oral cavity and pharynx. (2001) (54)
A recurrent mutation in PARK2 is associated with familial lung cancer. (2015) (54)
XPD / ERCC 2 polymorphisms and risk of head and neck cancer : a case-control analysis (2000) (54)
Genetic susceptibility to tobacco carcinogenesis. (1999) (54)
Association between family history of cancer and mutagen sensitivity in upper aerodigestive tract cancer patients. (1993) (54)
172G>T variant in the 5' untranslated region of DNA repair gene RAD51 reduces risk of squamous cell carcinoma of the head and neck and interacts with a P53 codon 72 variant. (2006) (54)
Integrative epidemiology: from risk assessment to outcome prediction. (2005) (54)
Genome-wide gene–environment interaction analysis for asbestos exposure in lung cancer susceptibility (2012) (53)
Wnt Signaling Pathway Pharmacogenetics in Non-Small Cell Lung Cancer (2014) (53)
Reduced DNA Repair Capacity for Removing Tobacco Carcinogen–Induced DNA Adducts Contributes to Risk of Head and Neck Cancer but not Tumor Characteristics (2010) (53)
Cancer chemoprevention in the 21st century: genetics, risk modeling, and molecular targets. (2000) (53)
Training future pharmacists at a minority educational institution: evaluation of the Rx for change tobacco cessation training program. (2004) (52)
Genetically Abnormal Circulating Cells in Lung Cancer Patients: An Antigen-Independent Fluorescence In situ Hybridization–Based Case-Control Study (2010) (52)
Bridging the clinical gaps: genetic, epigenetic and transcriptomic biomarkers for the early detection of lung cancer in the post-National Lung Screening Trial era (2013) (52)
Myeloperoxidase G-463A polymorphism and lung cancer: A HuGE Genetic Susceptibility to Environmental Carcinogens pooled analysis (2007) (52)
The association of microsomal epoxide hydrolase polymorphisms and lung cancer risk in African-Americans and Mexican-Americans. (2001) (52)
Death receptor 4 and bladder cancer risk. (2003) (51)
The Influence of Tumor Necrosis Factor-α −308 G/A and IL-6 −174 G/C on Pain and Analgesia Response in Lung Cancer Patients Receiving Supportive Care (2008) (51)
Cigarette smoking patterns in patients after treatment of upper aerodigestive tract cancers. (1990) (51)
Polymorphisms of DNA repair gene XRCC 1 in squamous cell carcinoma of the head and neck (1999) (50)
Mutagen Sensitivity and Genetic Variants in Nucleotide Excision Repair Pathway: Genotype-Phenotype Correlation (2007) (50)
Combined Effects of the p53 and p73 Polymorphisms on Lung Cancer Risk (2006) (49)
Symptom clusters of pain, depressed mood, and fatigue in lung cancer: assessing the role of cytokine genes (2013) (48)
Germline genetic variations in drug action pathways predict clinical outcomes in advanced lung cancer treated with platinum-based chemotherapy (2008) (48)
Chipping away at the genetics of smoking behavior (2010) (48)
Association between the V109G Polymorphism of the p27 Gene and the Risk and Progression of Oral Squamous Cell Carcinoma (2004) (48)
Polymorphisms of STK15 (Aurora-A) gene and lung cancer risk in Caucasians. (2006) (48)
Expression of methylation-related genes is associated with overall survival in patients with non-small cell lung cancer (2008) (48)
The evolving discipline of molecular epidemiology of cancer. (2010) (48)
Cell cycle checkpoints, DNA damage/repair, and lung cancer risk. (2005) (47)
Development of common data elements: the experience of and recommendations from the early detection research network (2003) (47)
Serum levels of insulin-like growth factor I and risk of squamous intraepithelial lesions of the cervix. (2003) (47)
Cancer Pharmacogenomics and Pharmacoepidemiology: Setting a Research Agenda to Accelerate Translation (2010) (47)
A case-control study of nonrandom distribution of bleomycin-induced chromatid breaks in lymphocytes of lung cancer cases. (1995) (46)
Vasectomy and prostate cancer risk in China. (1994) (46)
Genetic Variants in the PI3K/PTEN/AKT/mTOR Pathway Predict Head and Neck Cancer Patient Second Primary Tumor/Recurrence Risk and Response to Retinoid Chemoprevention (2012) (46)
Genome-wide association study reveals novel genetic determinants of DNA repair capacity in lung cancer. (2013) (46)
Epidemiologic determinants of clinically relevant prostate cancer (2000) (46)
Smoking-related genomic signatures in non-small cell lung cancer. (2008) (45)
An association between a NQO1 genetic polymorphism and risk of lung cancer. (2005) (45)
Sensation seeking, risk behaviors, and alcohol consumption among Mexican origin youth. (2011) (45)
Ethnic patterns of Hodgkin's disease incidence among children and adolescents in the United States, 1973-82. (1986) (44)
Dietary carotenoids and genetic instability modify bladder cancer risk. (2004) (44)
Automated detection of genetic abnormalities combined with cytology in sputum is a sensitive predictor of lung cancer (2008) (44)
Polymorphisms in XPD Exons 10 and 23 and Bladder Cancer Risk (2005) (44)
Genetic and nongenetic covariates of pain severity in patients with adenocarcinoma of the pancreas: assessing the influence of cytokine genes. (2009) (43)
In vitro BPDE‐induced DNA adducts in peripheral lymphocytes as a risk factor for squamous cell carcinoma of the head and neck (2001) (43)
“Drivers” of Translational Cancer Epidemiology in the 21st Century: Needs and Opportunities (2013) (43)
Exposure to Smoking Imagery in the Movies and Experimenting with Cigarettes among Mexican Heritage Youth (2009) (43)
Comparison of Pathway Analysis Approaches Using Lung Cancer GWAS Data Sets (2012) (42)
Cryopreserving whole blood for functional assays using viable lymphocytes in molecular epidemiology studies. (2001) (42)
Mutagen sensitivity as a susceptibility marker for human hepatocellular carcinoma. (1998) (42)
Bladder cancer risk as modified by family history and smoking (2006) (42)
Lung cancer, smoking patterns, and mutagen sensitivity in Mexican-Americans. (1995) (42)
Ethyl alcohol as a cocarcinogen with special reference to the aerodigestive tract: a cytogenetic study. (1991) (41)
Relationship Between Plasma Carotenoids and Prostate Cancer (2005) (41)
Age-related differences in factors associated with smoking initiation (2007) (40)
Sociodemographic characteristics, health beliefs, and the accuracy of cancer knowledge (2009) (40)
Evaluation of Mexican American migrant farmworker work practices and organochlorine pesticide metabolites. (2001) (39)
Family history of cancer, mutagen sensitivity, and increased risk of head and neck cancer. (1999) (39)
Psychosocial risk and correlates of early menarche in Mexican-American girls. (2011) (39)
Mutagen sensitivity as a predictor of tumor recurrence in patients with cancer of the upper aerodigestive tract. (1998) (39)
Associations among telomerase activity, p53 protein overexpression, and genetic instability in lung cancer (1999) (39)
Limiting the location of a putative human prostate cancer tumor suppressor gene at chromosome 13q14.3 (1999) (39)
A case-control study of prostate cancer. (1989) (39)
Microsomal epoxide hydrolase polymorphisms and lung cancer risk in non‐Hispanic whites (2002) (39)
Neuroblastoma: case-control analysis of birth characteristics. (1985) (39)
Genome-wide association study confirms lung cancer susceptibility loci on chromosomes 5p15 and 15q25 in an African-American population. (2016) (38)
An epidemiologic study of early onset lung cancer. (2006) (38)
Evaluation of Association of HNF1B Variants with Diverse Cancers: Collaborative Analysis of Data from 19 Genome-Wide Association Studies (2010) (37)
Complex segregation analysis reveals a multigene model for lung cancer (2004) (37)
CYP2A6 reduced activity gene variants confer reduction in lung cancer risk in African American smokers--findings from two independent populations. (2015) (37)
Dietary α‐, β‐, γ‐ and δ‐tocopherols in lung cancer risk (2008) (37)
Evaluation of glutathione S‐transferase polymorphisms and mutagen sensitivity as risk factors for the development of second primary tumors in patients previously diagnosed with early‐stage head and neck cancer (2006) (36)
Roles of tumor suppressor and telomere maintenance genes in cancer and aging--an epidemiological study. (2005) (36)
Rapid method for determination of DNA repair capacity in human peripheral blood lymphocytes amongst smokers (2010) (36)
Modification of lung cancer susceptibility by green tea extract as measured by the comet assay. (2002) (36)
No Association between hOGG1 Ser326Cys polymorphism and risk of squamous cell carcinoma of the head and neck. (2004) (36)
DNA Repair Capacity and Lung Cancer Risk in Never Smokers (2008) (36)
A statistical analysis of the reliability and classification error in application of the mutagen sensitivity assay. (1996) (35)
Genetic Risk Can Be Decreased: Quitting Smoking Decreases and Delays Lung Cancer for Smokers With High and Low CHRNA5 Risk Genotypes — A Meta-Analysis (2016) (35)
Variants in folate pathway genes as modulators of genetic instability and lung cancer risk (2011) (35)
Case-Control Analysis of Dietary Folate and Risk of Bladder Cancer (2005) (35)
ATM sequence variants associate with susceptibility to non‐small cell lung cancer (2007) (34)
Ethnic differences in poly(ADP-ribose) polymerase pseudogene genotype distribution and association with lung cancer risk. (1999) (34)
Epidemiology, biology, and chemoprevention of aerodigestive cancer (1994) (34)
Mutagen Sensitivity and Neoplastic Progression in Patients with Barrett's Esophagus: A Prospective Analysis (2006) (34)
Role of Selected Genetic Variants in Lung Cancer Risk in African Americans (2013) (34)
Fine-mapping of the 5p15.33, 6p22.1-p21.31, and 15q25.1 Regions Identifies Functional and Histology-Specific Lung Cancer Susceptibility Loci in African-Americans (2012) (34)
Gender Difference in Smoking Effect on Chromosome Sensitivity to Gamma Radiation in a Healthy Population (2000) (34)
Variants in inflammation genes are implicated in risk of lung cancer in never smokers exposed to second-hand smoke. (2011) (34)
Distinct Loci in the CHRNA5/CHRNA3/CHRNB4 Gene Cluster Are Associated With Onset of Regular Smoking (2013) (33)
Genetic variations in the transforming growth factor-beta pathway as predictors of survival in advanced non-small cell lung cancer. (2011) (33)
AACR Cancer Progress Report 2012 (2012) (33)
Smoking Initiation Among Mexican Heritage Youth and the Roles of Family Cohesion and Conflict. (2015) (32)
The Biology of Tobacco and Nicotine: Bench to Bedside (2005) (32)
Dietary Patterns Affect Lung Cancer Risk in Never Smokers (2011) (32)
γ-radiation-induced G2 delay, apoptosis, and p53 response as potential susceptibility markers for lung cancer (2001) (32)
Association of Genetic Variants of O6-Methylguanine-DNA Methyltransferase with Risk of Lung Cancer in Non-Hispanic Whites (2006) (32)
Increased plasma levels of angiogenin and the risk of bladder carcinoma (2005) (32)
Inflammatory gene polymorphisms influence risk of postoperative morbidity after lung resection. (2005) (32)
Eliminating second-hand smoke from Mexican-American households: outcomes from Project Clean Air-Safe Air (CASA). (2013) (32)
Genetic polymorphisms in double-strand break DNA repair genes associated with risk of oral premalignant lesions. (2008) (32)
Global Assessment of Genetic Variation Influencing Response to Retinoid Chemoprevention in Head and Neck Cancer Patients (2011) (32)
Investigating Multiple Candidate Genes and Nutrients in the Folate Metabolism Pathway to Detect Genetic and Nutritional Risk Factors for Lung Cancer (2013) (31)
Benzo[a]pyrene diol epoxide-induced 3p21.3 aberrations and genetic predisposition to lung cancer. (1998) (31)
Polymorphisms of cytosolic serine hydroxymethyltransferase and risk of lung cancer: a case-control analysis. (2007) (31)
Hierarchical modeling identifies novel lung cancer susceptibility variants in inflammation pathways among 10,140 cases and 11,012 controls (2013) (31)
Multistage Analysis of Variants in the Inflammation Pathway and Lung Cancer Risk in Smokers (2012) (31)
XRCC3 genetic polymorphism, smoking, and lung carcinoma risk in minority populations (2003) (31)
Haplotypes of two variants in p16 (CDKN2/MTS-1/INK4a) exon 3 and risk of squamous cell carcinoma of the head and neck: a case-control study. (2002) (31)
Integrative cancer epidemiology--the next generation. (2012) (30)
Androgen receptor polymorphisms and risk of biochemical failure among prostatectomy patients (2004) (30)
CYP2E1 G1532C, NQO1 Pro187Ser, and CYP1B1 Val432Leu Polymorphisms Are Not Associated with Risk of Squamous Cell Carcinoma of the Head and Neck (2005) (30)
Whole exome sequencing analysis in severe chronic obstructive pulmonary disease (2018) (30)
Admixture mapping of lung cancer in 1812 African-Americans. (2011) (29)
Seizure 6-like (SEZ6L) gene and risk for lung cancer. (2007) (29)
Genetic susceptibility to lung cancer as determined by lymphocytic chromosome analysis. (1995) (28)
The Cytokinesis-Blocked Micronucleus Assay as a Strong Predictor of Lung Cancer: Extension of a Lung Cancer Risk Prediction Model (2014) (28)
Single Nucleotide Polymorphisms in Selected Apoptotic Genes and BPDE-Induced Apoptotic Capacity in Apparently Normal Primary Lymphocytes: A Genotype-Phenotype Correlation Analysis (2008) (28)
Method for Evaluating Multiple Mediators: Mediating Effects of Smoking and COPD on the Association between the CHRNA5-A3 Variant and Lung Cancer Risk (2012) (28)
Dietary alpha-, beta-, gamma- and delta-tocopherols in lung cancer risk. (2008) (28)
Re: Discriminatory accuracy from single-nucleotide polymorphisms in models to predict breast cancer risk. (2009) (28)
Prospective analysis of DNA damage and repair markers of lung cancer risk from the Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial. (2010) (27)
Mutagen sensitivity as a marker of cancer risk. (1994) (27)
In vitro protective effects of chemopreventive agents against bleomycin-induced genotoxicity in lymphoblastoid cell lines and peripheral blood lymphocytes of head and neck cancer patients. (1993) (27)
Mutagen sensitivity exhibits a dose-response relationship in case-control studies. (1996) (27)
Influence of subjective social status on the relationship between positive outcome expectations and experimentation with cigarettes. (2009) (27)
An analysis of single nucleotide polymorphisms of 125 DNA repair genes in the Texas genome-wide association study of lung cancer with a replication for the XRCC4 SNPs. (2011) (27)
A Modified Host Cell Reactivation Assay to Measure DNA Repair Capacity for Removing 4-Aminobiphenyl Adducts: A Pilot Study of Bladder Cancer (2005) (26)
Gamma-radiation-induced single cell DNA damage as a measure of susceptibility to lung cancer: a preliminary report. (2000) (26)
Sensation‐seeking genes and physical activity in youth (2013) (26)
Joint Effects of Dietary Trace Metals and DNA Repair Capacity in Lung Cancer Risk (2007) (25)
Cognitive Susceptibility to Smoking: Two Paths to Experimenting among Mexican Origin Youth (2009) (25)
Incidence of salivary gland cancer in the United States relative to ultraviolet radiation exposure. (2007) (25)
Genetic variations in cell‐cycle pathway and the risk of oral premalignant lesions (2008) (25)
The development of a comprehensive, institution-based patient risk evaluation program: I. Development, content, and data management. (1988) (25)
Strategies for chemoprevention study of premalignancy and second primary tumors in the head and neck (1995) (24)
Incidence of prostate cancer and marital status. (1987) (24)
Interplay between mutagen sensitivity and epidemiological factors in modulatinglung cancer risk (2006) (24)
Focused Analysis of Exome Sequencing Data for Rare Germline Mutations in Familial and Sporadic Lung Cancer (2016) (23)
3p22.1 and 10q22.3 Deletions Detected by Fluorescence In Situ Hybridization (FISH): A Potential New Tool for Early Detection of Non-small Cell Lung Cancer (NSCLC) (2008) (23)
Cancer prevention practices among Texas primary care physicians. (1992) (23)
Chromosome 5 aberrations and genetic predisposition to lung cancer (1998) (23)
Overexpression of hMTH in peripheral lymphocytes and risk of prostate cancer: a case‐control analysis (2003) (22)
Comparison of Haplotype Inference Methods Using Genotypic Data from Unrelated Individuals (2004) (22)
Seasonal diagnosis of Hodgkin's disease among young adults. (1985) (22)
E‐cadherin promoter polymorphism (C‐160A) and risk of recurrence in patients with superficial bladder cancer (2006) (22)
Myeloperoxidase promoter region polymorphism and lung cancer risk. (2003) (21)
Consensus statements from the Second International Lung Cancer Molecular Biomarkers Workshop: a European strategy for developing lung cancer molecular diagnostics in high risk populations. (2002) (20)
Polymorphism of DNA ligase I and risk of lung cancer--a case-control analysis. (2002) (20)
Mutagen sensitivity as a marker of cancer susceptibility (1996) (20)
Genetic Susceptibility for Lung Cancer: Interactions with Gender and Smoking History and Impact on Early Detection Policies (2003) (20)
Month-of-birth and incidence of acute lymphoblastic leukemia in children. (1996) (20)
A modified host-cell reactivation assay to measure repair of alkylating DNA damage for assessing risk of lung adenocarcinoma. (2007) (20)
Smoking affects treatment outcome in patients with advanced non-small cell lung cancer. (2004) (19)
A smoking‐based carcinogenesis model for lung cancer risk prediction (2011) (19)
Association between malignancies of the upper aerodigestive tract and uterine cervix (1992) (19)
The development of a comprehensive, institution-based patient risk evaluation program: II. Validity and reliability of questionnaire data. (1988) (19)
Use of the Cytokinesis-Blocked Micronucleus Assay to Detect Gender Differences and Genetic Instability in a Lung Cancer Case–Control Study (2012) (19)
Lung Cancer Risk in Never-Smokers of European Descent is Associated With Genetic Variation in the 5p15.33 TERT-CLPTM1Ll Region. (2019) (19)
Joint Effect of Mutagen Sensitivity and Insulin-Like Growth Factors in Predicting the Risk of Developing Secondary Primary Tumors and Tumor Recurrence in Patients with Head and Neck Cancer (2006) (19)
Three measures of mutagen sensitivity in a cancer-free population. (1999) (19)
The associations of body image, anxiety, and smoking among Mexican-origin youth. (2013) (19)
D 2 Dopamine Receptor Gene Polymorphisms among African-Americans and Mexican-Americans : A Lung Cancer Case-Control Study 1 (2000) (18)
Effects of 9-cis-retinoic acid on the insulin-like growth factor axis in former smokers. (2005) (18)
Low incidence of familial breast cancer among Hispanic women (1992) (18)
Polymorphisms and haplotypes of serine hydroxymethyltransferase and risk of squamous cell carcinoma of the head and neck: a case–control analysis (2005) (18)
Cigarette smoking patterns of cancer patients. (1990) (18)
XPD/ERCC2 EXON 8 Polymorphisms: rarity and lack of significance in risk of squamous cell carcinoma of the head and neck. (2002) (18)
Association of smoking with tumor size at diagnosis in non-small cell lung cancer. (2011) (17)
Cigarette Experimentation in Mexican Origin Youth: Psychosocial and Genetic Determinants (2011) (17)
Association of a novel functional promoter variant (rs2075533 C>T) in the apoptosis gene TNFSF8 with risk of lung cancer--a finding from Texas lung cancer genome-wide association study. (2011) (17)
Deficient G2-M and S Checkpoints are Associated with Increased Lung Cancer Risk: A Case-Control Analysis (2007) (17)
Estimation of the effects of smoking and DNA repair capacity on coefficients of a carcinogenesis model for lung cancer (2009) (17)
Chromosomal Instability in Peripheral Blood Lymphocytes and Risk of Prostate Cancer (2005) (17)
Reduced expression of hMSH2 and hMLH1 and risk of prostate cancer: A case‐control study (2001) (17)
Gamma-radiation-induced G2 delay, apoptosis, and p53 response as potential susceptibility markers for lung cancer. (2001) (17)
Methyl‐CpG‐binding domain 2 (2004) (16)
GPC5 rs2352028 variant and risk of lung cancer in never smokers. (2010) (16)
Rare Variants in Known Susceptibility Loci and Their Contribution to Risk of Lung Cancer (2018) (16)
Chromosome instability and risk of squamous cell carcinomas of head and neck. (2008) (15)
Salivary gland cancer and risk of subsequent skin cancer (1990) (15)
Trends in prevalence of prognostic factors and survival in lung cancer patients from 1985 to 2004 at a tertiary care center. (2008) (15)
Human sensitivity to PhIP: a novel marker for prostate cancer risk. (2006) (15)
A Case–Control Study of a Sex-Specific Association between a 15q25 Variant and Lung Cancer Risk (2011) (15)
Questionable relationship between cholecystectomy and colon cancer (1985) (15)
A clinical trial to evaluate the effect of vitamin C supplementation on in vitro mutagen sensitivity. The University of Texas M. D. Anderson Clinical Community Oncology Program Network. (1997) (15)
Nitrite inhalants: historical perspective. (1988) (14)
Deletion in poly(ADP-ribose)polymerase pseudogene and lung cancer risk. (1998) (14)
Heme‐related gene expression signatures of meat intakes in lung cancer tissues (2014) (14)
A Functional Variant of Tandem Repeats in Human Telomerase Gene Was Associated with Survival of Patients with Early Stages of Non–Small Cell Lung Cancer (2010) (14)
Unopposed estrogen and estrogen plus progestin menopausal hormone therapy and lung cancer risk in the NIH–AARP Diet and Health Study Cohort (2012) (14)
Common genetic variants in cell cycle pathway are associated with survival in stage III-IV non-small-cell lung cancer. (2011) (13)
Multiple Primary Cancer Risk in Patients with Major Salivary Gland Carcinoma (1985) (13)
Differential Induction in Telomerase Activity among Bladder Cancer Patients and Controls on γ-Radiation (2007) (13)
Chromosome breaks and sister chromatid exchange as predictors of second cancers in Hodgkin's disease. (1998) (13)
Predictors of Survival in Never-Smokers with Non–Small Cell Lung Cancer: A Large-Scale, Two-Phase Genetic Study (2012) (13)
Self-Rated Health Among Adult Women of Mexican Origin (2006) (13)
Season-of-birth and acute leukemia of infancy. (1989) (13)
Blood-Based Biomarker Panel for Personalized Lung Cancer Risk Assessment (2022) (13)
Comparative efficacy as antioxidants between ascorbic acid and epigallocatechin gallate on cells of two human lymphoblastoid lines. (2001) (12)
Experimenting with cigarettes and physical activity among Mexican origin youth: a cross sectional analysis of the interdependent associations among sensation seeking, acculturation, and gender (2012) (12)
Erratum: Phytoestrogen intake and prostate cancer: A case-control study using a new database (Nutrition and Cancer (1999) 33:1 (22-23)) (2000) (12)
Cross-Cancer Pleiotropic Associations with Lung Cancer Risk in African Americans (2018) (12)
Informed Genome‐Wide Association Analysis With Family History As a Secondary Phenotype Identifies Novel Loci of Lung Cancer (2015) (12)
Association study of nicotinic acetylcholine receptor genes identifies a novel lung cancer susceptibility locus near CHRNA1 in African-Americans (2012) (12)
Gene by Environment Investigation of Incident Lung Cancer Risk in African-Americans (2016) (12)
DNA Repair Gene ERCC 1 and ERCC 2 / XPD Polymorphisms and Risk of Squamous Cell Carcinoma of the Head and Neck (2002) (12)
Leukemia and cigarette smoking (1990) (12)
DNA repair and genomic instability in tobacco induced malignancies of the lung and upper aerodigestive tract (1998) (11)
Identification of lung cancer histology-specific variants applying Bayesian framework variant prioritization approaches within the TRICL and ILCCO consortia. (2015) (11)
Shared cytogenetic abnormalities in lung-tumors and corresponding peripheral-blood lymphocytes. (1995) (11)
A Genome-wide Association Study of Lung Cancer Identifies a Region of Chromosome 5p15 Associated with Risk for Adenocarcinoma. (2011) (11)
Analysis of aromatic DNA adducts and 7,8-dihydro-8-oxo- 2'-deoxyguanosine in lymphocyte DNA from a case-control study of lung cancer involving minority populations. (2000) (11)
Incidence of testicular cancer in the United States related to marital status, histology, and ethnicity. (1987) (11)
Derived SNP Alleles are Used More Frequently than Ancestral Alleles as Risk-associated Variants in Common Human Diseases (2012) (11)
BPDE‐induced lymphocytic 3p21.3 aberrations may predict head and neck carcinoma risk (2002) (11)
Benzo[a]pyrene diol epoxide‐induced 9p21 aberrations associated with genetic predisposition to bladder cancer (2004) (10)
Discovery and fine-mapping of height loci via high-density imputation of GWASs in individuals of African ancestry. (2021) (10)
The next generation of large-scale epidemiologic research: implications for training cancer epidemiologists. (2014) (10)
Pilot Study of CYP2B6 Genetic Variation to Explore the Contribution of Nitrosamine Activation to Lung Carcinogenesis (2013) (10)
Risk factors and genetic susceptibility. (1995) (10)
Exposure to Pro-tobacco Messages and Smoking Status Among Mexican Origin Youth (2014) (10)
High Mutagen Sensitivity in Peripheral Blood Lymphocytes Predicts Poor Overall and Disease-Specific Survival in Patients with Stage III Non–Small Cell Lung Cancer Treated with Radiotherapy and Chemotherapy (2005) (10)
Chapter 11: Rice‐MD Anderson Lung Cancer Model (2012) (9)
A genetic variant near the PMAIP1/Noxa gene is associated with increased bleomycin sensitivity. (2011) (9)
PACE-setting research (1997) (9)
Gender differences in sociodemographic and behavioral influences of physical activity in Mexican-origin adolescents. (2012) (9)
Survival of cells with bleomycin-induced chromosomal lesions in the cultured lymphocytes of lung cancer patients. (1996) (9)
Inflammation-related Genetic Variations and Survival for Advanced Non-Small Cell Lung Cancer Receiving First-line Chemotherapy (2014) (9)
Association between the V 109 G Polymorphism of the p 27 Gene and the Risk and Progression of Oral Squamous Cell Carcinoma (2004) (9)
Re: "Cancer mortality among US men and women with asthma and hay fever". (2006) (9)
Demographic, psychosocial, and genetic risk associated with smokeless tobacco use among Mexican heritage youth (2015) (8)
Subgroup report: head and neck cancer. (2004) (8)
Cotinine conundrum--a step forward but questions remain. (2012) (8)
Analysis of aromatic DNA adducts and 7,8‐dihydro‐8‐oxo‐2′ deoxyguanosine in lymphocyte DNA from a case‐control study of lung cancer involving minority populations (2000) (8)
Rare deleterious germline variants and risk of lung cancer (2021) (8)
Polymorphic hCHK2/hCds1 codon 84 allele and risk of squamous cell carcinoma of the head and neck--a case-control analysis. (2001) (8)
Genetic instability of specific chromosomes associated with a family history of cancer. (2002) (8)
A Risk Prediction Model for Smoking Experimentation in Mexican American Youth (2014) (7)
Abstract 2931: Inherited variation at chromosome 12p13.33 includingRAD52influences squamous cell lung carcinoma risk (2012) (7)
Sex chromosome abnormalities in lung cancer patients. (1996) (7)
Increased plasma levels of angiogenin and the risk of bladder carcinoma: from initiation ot recurrence. (2005) (7)
A case‐control analysis of lymphocytic chromosome 9 aberrations in lung cancer (2002) (7)
Polymorphisms in the N acetyltransferase 1 NAT1 gene and lung cancer risk in a minority population. (1998) (7)
Profiles of cigarette smoking among patients in a cancer center. (1988) (7)
Combined Effects of the p 53 and p 73 Polymorphisms on Lung Cancer Risk (2006) (7)
Subfertility: an etiologic factor in development of testicular cancer? (1987) (6)
Evaluation of sister chromatid exchange and chromosome breaks in a cohort of untreated Hodgkin's disease patients. (1997) (6)
B7-07: Deletion of chromosome 10q detected by Fluorescent In Situ Hybridization (FISH) is a potential new tool for early detection of Non Small Cell Lung Cancer (NSCLC) (2007) (6)
Genetic Susceptibility to Lung Cancer (2003) (6)
Prematurity and risk of childhood cancer. (1986) (6)
Association of Genetic Variants of O 6-Methylguanine-DNA Methyltransferase with Risk of Lung Cancer in Non-Hispanic Whites (2006) (6)
Cross-ancestry genome-wide meta-analysis of 61,047 cases and 947,237 controls identifies new susceptibility loci contributing to lung cancer (2022) (6)
Molecular dosimeters of smoking damage in the lung. (1999) (6)
Assessing environmental and occupational risk factors for lung cancer in Mexican–Americans (2010) (6)
Strategies to Identify Pharmacogenomic Biomarkers: Candidate Gene, Pathway-Based, and Genome-Wide Approaches (2008) (6)
Joint effect of insulin-like growth factors and mutagen sensitivity in lung cancer risk. (2000) (6)
Specific chromosome aberrations in peripheral blood lymphocytes are associated with risk of bladder cancer (2004) (5)
Improving residents' knowledge of cancer prevention: are physicians prepared for prevention? (2009) (5)
Activating enhancer-binding protein-2β nucleolar localization predicts poor survival after stage I non-small cell lung cancer resection. (2011) (5)
A second genetic variant on chromosome 15q24-25.1 associates with lung cancer. (2010) (5)
Genome-wide scan of 29,141 African Americans finds no evidence of selection since admixture (2013) (5)
Education and lung cancer among never smokers. (2014) (4)
Strategies to Improve Healthcare Websites (2006) (4)
Occupational exposure to silica and cancer risk (2004) (4)
Recommendations for Cancer Prevention (1992) (4)
Self-Reported Prior Lung Diseases as Risk Factors for Non-small Cell Lung Cancer in Mexican Americans (2013) (4)
Risk profiles of women with cervical neoplasia. (1991) (4)
Corrigendum: Rare variants of large effect in BRCA2 and CHEK2 affect risk of lung cancer (2017) (4)
Chapter 3. Lung Cancer Susceptibility and Risk Assessment Models (2008) (3)
Excess leukemia and multiple myeloma in a mining county in northeast Texas. (1994) (3)
Automated detection of genetic abnormalities combined with cytology in sputum is a sensitive predictor of lung cancer (2009) (3)
p73 G4C14-to-A4T14 gene polymorphism and interaction with p53 exon 4 Arg72Pro on cancer susceptibility: a meta-analysis of the literature. (2012) (3)
Hamilton et al. Respond to “Consolidating Data Harmonization” (2011) (3)
Viewing images of alcohol use in PG-13-rated movies and alcohol initiation in Mexican-heritage youth (2019) (3)
O-055 Dietary phytoestrogens and lung cancer risk (2005) (3)
Lung carcinoma patients with a family history of cancer and lymphocyte primary chromosome 9 aberrations (1997) (3)
Cancer risk and early detection assessment. (1993) (3)
Smoking and Genetic Risk Variation Across Populations of European, Asian, and African American Ancestry—A Meta‐Analysis of Chromosome 15q25 (2012) (3)
Lower lung cancer rates in Jewish smokers in Israel and the USA (2015) (2)
Epidemiology--found in translation. (2011) (2)
Genetic and environmental interactions as risks for aerodigestive cancers. (1992) (2)
Pelvic Adhesions in Intrauterine Device Users (1988) (2)
Epidemiologic similarities leading to etiologic hypotheses. (1987) (2)
Lung cancer risk factors in a minority population (2006) (2)
Misclassification of Body Mass Index (BMI) Using Self-Reported Weight and Height in an Urban Mexican-American Population (2005) (2)
COMMENT ON: BENZOAPYRENE DIOL EPOXIDE AND BLEOMYCIN SENSITIVITY AND SUSCEPTIBILITY TO CANCER OF UPPER AERODIGESTIVE TRACT. AUTHORS' REPLY (1999) (2)
Erratum: Automated detection of genetic abnormalities combined with cytology in sputum is a sensitive predictor of lung cancer (Modern Pathology (2008) 21 (950-960) DOI:10.1038/modpathol.2008.71) (2008) (2)
Serum Insulin-like Growth Factor (IGF) and IGF-binding Protein Levels and Risk of Lung Cancer (2002) (2)
Lung carcinoma patients with a family history of cancer and lymphocyte primary chromosome 9 aberrations. (1997) (2)
Maternal current smoking: concordance between adolescent proxy and mother's self-report. (2009) (2)
Mutagen sensitivity may predict lung protection by amifostine for patients with locally advanced non-small cell lung cancer treated by chemoradiotherapy. (2005) (2)
Lung cancer after breast cancer: the role of radiation therapy and smoking (1999) (2)
An Informatics Tool to Assess Individualized Colon Cancer Risk (2005) (2)
Irradiation‐induced telomerase activity and the risk of lung cancer (2007) (2)
Fine-mapping of the 5 p 15 . 33 , 6 p 22 . 1p 21 . 31 , and 15 q 25 . 1 Regions Identi fi es Functional and Histology-Speci fi c Lung Cancer Susceptibility Loci in African-Americans (2013) (2)
Cancer Epidemiology in the 21 st Century " Drivers " of Translational Cancer Epidemiology in the 21 st Century : Needs and Opportunities (2013) (2)
Automated detection of genetic abnormalities combined with cytology in sputum is a sensitive predictor of lung cancer (2008) (1)
Serum Insulin-like Growth Factor ( IGF ) and IGF-binding Protein Levels and Risk of Lung Cancer : A Case-Control Study Nested in the-Carotene and Retinol Efficacy Trial Cohort 1 (2002) (1)
Nucleotide excision repair genes and lung cancer risk: A pathway-based approach (2005) (1)
‘Confounding’ Our Future (2011) (1)
Abstract PR-03: Genetic variations in microRNA biogenesis genes as predictors for risk of second primary tumor (SPT) and/or recurrence in patients with early‐stage head and neck cancer (2010) (1)
Abstract 5475: Wnt pathway pharmacogenetics in lung cancer patients treated with platinum regimens (2011) (1)
Association between glutathione S-transferase (GST) P1 polymorphisms and survival of patients with advanced non-small cell lung cancer (NSCLC). (2004) (1)
Abstract 1584: Transcriptome analysis links immune genes allelic expression imbalances to lung cancer (2019) (1)
Abstract #LB-139: A comprehensive genome-wide association study of lung cancer (2009) (1)
Abstract 4092: Aberrant miRNA methylation in tumors from surgically resected lung cancer patients and association with survival (2010) (1)
Association between Low Dietary Folate Intake and Suboptimal Cellular DNA Repair Capacity 1 (2003) (1)
Inflammation genes and pain severity in lung cancer patients. (2009) (1)
Eleventh Annual AACR American Cancer Society Award for Research in Epidemiology or Prevention Lecture Genetic Susceptibility to Lung Cancer: The Role of DNA Damage and Repair 1,2 (2003) (1)
Predictive Biomarkers and Personalized Medicine Genetic Variants in the PI 3 K / PTEN / AKT / mTOR Pathway Predict Head and Neck Cancer Patient Second Primary Tumor / Recurrence Risk and Response to Retinoid Chemoprevention (2012) (1)
Abstract 287: Deletion of 3p22.1 by FISH in non-small cell lung cancer (NSCLC) is significantly correlated with loss of β-catenin membrane expression and dysregulated cell adhesion. (2013) (1)
Abstract A127: Comparison of discriminatory power and accuracy of three lung cancer risk models (2010) (1)
ABSTRACTS 32nd Annual Meeting • American Society of Preventive Oncology, Bethesda, Maryland • March 16-18, 2008 (2008) (1)
Cigarette Experimentation and the Population Attributable Fraction for Associated Genetic and Non-Genetic Risk Factors (2013) (1)
Abstract 1675: Lung cancer chemotherapy: genetic variations in the transforming growth factor beta pathway as predictors of survival (2010) (1)
Environmental carcinogenesis and its prevention: the head and neck cancer model. (1993) (1)
Lung cancer and wood dust exposure (1995) (1)
1045 : p53 Polymorphisms Predict Poor Clinical Outcome in Non-Small-Cell Lung Cancer Patients Treated With Radiotherapy/Chemotherapy (2006) (1)
Meta-and pooled analysis of GSTM 1 and CYP 1 A 1 polymorphisms and oropharyngeal cancer : a HuGE-GSEC review (2014) (1)
Reply to K.A. Olaussen et al (2012) (1)
Diet and physical activity in lung cancer risk prediction for current, former, and never smokers. (2007) (1)
Molecular Epidemiology of Head and Neck Cancer (2003) (1)
Phytoestrogens and Risk of Lung Cancer—Reply (2006) (1)
Trans-ethnic genome-wide meta-analysis of 35,732 cases and 34,424 controls identifies novel genomic cross-ancestry loci contributing to lung cancer susceptibility (2020) (1)
Increased Risk of Lung Cancer DNA-Methyltransferase-3B Promoter Is Associated with an A Novel Polymorphism in Human Cytosine (2013) (0)
856: Dietary Carotenoids and Genetic Instability Modify Bladder Cancer Risk (2005) (0)
Integrative molecular epidemiology: From risk assessment to outcome prediction (2005) (0)
983: Bladder Cancer Predisposition: A Pathway-Based Approach to DNA Repair and Cell Cycle Control Genes (2006) (0)
Human Papillomavirus Type 16 Infection and Squamous Cell Carcinoma of the Head and Neck in Never-Smokers : A Matched Pair Analysis 1 (2003) (0)
Abstract 5229: Candidate gene analysis of exome sequencing data in smokers susceptible and resistant to chronic obstructive pulmonary disease (2016) (0)
Multigenic and dietary analysis of bladder cancer risk on special reference on nucleotide excision repair and folate intake (2004) (0)
Abstract B94: Pharmacogenetics of retinoid chemoprevention in head and neck cancer patients: Modulation of response by common genetic variation in the mTOR signaling pathway (2010) (0)
Room 501 A-C, Los Angeles Convention Center Epidemiology 11 Inflammation, Immunity, and Novel Pathways (2007) (0)
Correspondence re: M. T. Goodman et al., effects of beta-carotene and alpha-tocopherol on bleomycin-induced chromosomal damage. Cancer Epidemiol. Biomark. Prev., 7: 113-117, 1998. (1998) (0)
Abstract LB-400: Conventional and anti-microbial pesticide exposures and increased risk of lung cancer in Mexican Americans (2010) (0)
Abstract 4662: Genetic variations in the cell-cycle pathway and survival of patients with advanced non-small cell lung cancer receiving platinum-based chemotherapy (2010) (0)
Potential Susceptibility Markers For Lung Cancer -Radiation-induced G2 Delay, Apoptosis, and p53 Response as γ (2013) (0)
Abstract 1899: Validation of the Spitz lung cancer risk prediction model with the Dutch-Belgian randomized lung cancer screening trial (NELSON) cohort (2011) (0)
Pro-oxidants and Injury Effects : Contributors to Tobacco Carcinogenesis in the Lung ? (2005) (0)
HighMutagen Sensitivity in Peripheral Blood Lymphocytes Predicts Poor Overall and Disease-Specific Survival in Patients with Stage IIINon^Small Cell Lung Cancer Treatedwith Radiotherapy and Chemotherapy (2005) (0)
Smoking Experimentation, Moderate-to-Vigorous Physical Activity, and Associated Psychosocial and Demographic Correlates among Mexican Origin Youth (2018) (0)
The implementation and applications of a cancer patient risk evaluation questionnaire. (1989) (0)
Erratum: XID/ERCC2 polymorphisms and risk of head and neck cancer: A case control analysis (Carcinogenesis (2000) vol. 21 (2219-2224)) (2001) (0)
American Society of Cytopathology 56th Annual Scientific Meeting Platform and Poster Presentations (2008) (0)
Single-Nucleotide Polymorphisms, DNA Repair, and Cancer (2003) (0)
Abstract 4132: Expression of pattern recognition receptor genes and survival in colorectal adenocarcinoma (2014) (0)
Erratum to: Hierarchical modeling identifies novel lung cancer susceptibility variants in inflammation pathways among 10,140 cases and 11,012 controls (2016) (0)
Pharmacogenetics of lung cancer: An integrative epidemiologic approach (2008) (0)
Cancer Epidemiology in the 21 st Century Transforming Epidemiology for 21 st Century Medicine and Public Health (2013) (0)
Correction: Corrigendum: Rare variants of large effect in BRCA2 and CHEK2 affect risk of lung cancer (2017) (0)
Mutations in Nonmelanoma Skin Cancer of the Head and Neck : Molecular Evidence for Field Cancerization 1 (2006) (0)
Abstract 4600: Target exome sequencing for disease-causing rare mutations in familial and sporadic lung cancer (2015) (0)
Abstract 2929: Predictors of survival in never-smokers with non-small cell lung cancer: A large-scale, two-phase genetic study (2012) (0)
Genetic variations in chemotherapy drug action pathways modulate therapeutic response in esophageal cancer (2005) (0)
Abstract LB-406: A genetic variant near the PMAIP1/Noxa gene is associated with increased bleomycin sensitivity and cancer risk (2010) (0)
O-053 Building a comprehensive quantitative risk assessment modelfor lung cancer (2005) (0)
Use of telomere length in peripheral leukocytes to predict risk of recurrence in patients with early-stage non-small cell lung cancer after curative resection. (2010) (0)
Abstract CN14-01: A genome-wide association study identifies variation in nicotine acetylcholine receptors that influence risk for lung cancer and smoking behavior (2008) (0)
Abstract B109: Tea and coffee consumption, DNA repair, and lung cancer risk (2010) (0)
An informatics tool to assess colon cancer risk. (2005) (0)
Expressionof Telomere-AssociatedGenes as PrognosticMarkers for Overall Survival in Patients with Non ^ Small Cell Lung Cancer (2006) (0)
Abstract 2849: A functional promoter variant (rs2075533 C>T) inTNFSF8 involved in apoptosis contributes to decreased risk of lung cancer — a finding from Texas lung cancer genome-wide association study (2010) (0)
Unopposed estrogen and estrogen plus progestin menopausal hormone therapy and lung cancer risk in the NIH–AARP Diet and Health Study Cohort (2012) (0)
Abstract 2879: Profiling of lung microbial communities in lung cancer and chronic obstructive pulmonary disease patients (2015) (0)
An Epidemiologic Approach to Outcome Prediction (2006) (0)
Early cancer detection: update for primary-care physicians. (1990) (0)
Abstract 4662: Genetic predictors of clinical outcomes for patients with non-small cell lung cancer (2011) (0)
Age and gender differences in the association between MPO 463>A and lung cancer. Results from the genetic susceptibility to environmental carcinogens pooled analysis (2006) (0)
' s response to reviews Title : Correlates of cognitive susceptibility to smoking among Mexican origin youth residing in (2008) (0)
3p and 10q deletions detected by fluorescence in situ hybridization (FISH): A potential new tool for early detection of non-small cell lung cancer (NSCLC) (2007) (0)
Abstract A6: Ethnic differences in risk of lung cancer associated with repair capacity for tobacco carcinogen‐induced DNA adduct (2010) (0)
Genome-wide association study confirms lung cancer susceptibility loci on chromosome 5p15 and 15q25 in an African-American population (2016) (0)
Erratum: Reduced expression levels of nucleotide excision repair genes in lung cancer: A case-control analysis (Carcinogenesis (2000) vol. 21 (1527-1530)) (2001) (0)
Response: Re: Benzo[a]pyrene Diol Epoxide and Bleomycin Sensitivity and Susceptibility to Cancer of Upper Aerodigestive Tract (1999) (0)
31st Annual Meeting • American Society of Preventive Oncology, Houston, Texas • March 2–4, 2007 (2007) (0)
Death Receptor 4 and Bladder Cancer Risk 1 (2003) (0)
Abstract A106: Optimal strategies for selecting samples for sequencing families with a common cancer: The Genetic Epidemiology of Lung Cancer Consortium. (2012) (0)
Gender-specific effects of dietary carotenoid intake on lung cancer risk (2007) (0)
Assessment of insulin-like growth factors and mutagen sensitivity as predictors of lung cancer risk. (2003) (0)
Abstract 857: A preliminary study of the correlation of tumor size and epidemiological characteristics in patients with non-small cell lung cancer (2010) (0)
Parental electromagnetic exposures and childhood cancer (1986) (0)
Hierarchical modeling identifies novel lung cancer susceptibility variants in inflammation pathways among 10,140 cases and 11,012 controls (2013) (0)
Abstract B136: Early age at menarche in Mexican American girls: Psychosocial risk factors (2010) (0)
E-76.Identifying the high risk subject: Assessment of DNA damage and repair (2003) (0)
Breakfast Consumption Among Mexican American Adolescents (2012) (0)
Abstract LB-186: Genetic variants and risk of lung cancer in never-smokers: A genome-wide association study (2010) (0)
Abstract 4149: Genetic variation in CYP2A6, a nicotine/nitrosamine metabolism enzyme, influences lung cancer risk in two independent case-control studies of African American smokers (2014) (0)
Abstract 1878: Evidence for the indirect relationship between self-reported exposure to environmental agents and smoking in the assessment of lung cancer risk (2011) (0)
Association of dietary magnesium and DNA repair capacity with lung cancer risk. (2006) (0)
4–2 Smoking and survival after breast cancer diagnosis (2008) (0)
Continued increase of testicular cancer in the United States (1994) (0)
Atlas do cancro em Portugal, 1980–82 (2004) (0)
Abstract IA21: Risk prediction models for lung cancer (2012) (0)
Title: Trans-ethnic genome-wide meta-analysis of 35,732 cases and 34,424 controls identifies novel genomic cross-ancestry loci contributing to lung cancer susceptibility (2020) (0)
Abstract #SY31-3: Lung cancer, smoking, and genetic susceptibility in African Americans (2009) (0)
Re: Identifying Mexican Americans. (1987) (0)
Chapter 17 SINGLE-NUCLEOTIDE POLYMORPHISMS , DNA REPAIR , AND CANCER (0)
ERRATUM (2000) (0)
Encouraging trends in lung cancer mortality in Texas, 1970 to 1986. (1989) (0)
Abstract B91: Self-reported prior lung disease as risk factors for non-small cell lung cancer in Mexican Americans (2011) (0)
Abstract 938: Inflammation and immune response pathway analysis of lung cancer using hierarchal modeling based on GWAS data (2010) (0)
Re: Benzo[α]pyrene diol epoxide and bleomycin sensitivity and susceptibility to cancer of upper aerodigestive tract [5] (multiple letters) (1999) (0)
C8-04: Genetic polymorphisms in cell cycle control pathways and lung cancer risk (2007) (0)
Mutagen Sensitivity (MS) may predict lung protection by amifostine for patients with locally advanced non-small cell lung cancer (NSCLC) treated by chemoradiotherapy. (2004) (0)
Genetic susceptibility to tobacco carcinogenesis: An integrative epidemiologic approach. (2006) (0)
Sex ratio of offspring of patients with prostatic cancer. (1986) (0)
Abstract 1345: Evidence for genetic mediation of lung cancer through hay fever. (2013) (0)
Abstract 4657: Identification and validation of genetic determinants of DNA repair phenotype in genome-wide association study of lung cancer (2011) (0)
AP2β nucleolar localization predicts poor survival after stage I non–small cell lung cancer resection (2012) (0)
A Single Nucleotide Polymorphism in the Matrix Metalloproteinase-1 Promoter Enhances Lung Cancer Susceptibility 1 (2001) (0)
The influence of polymorphisms in cytokine genes on pain and response to analgesia in lung cancer patients receiving palliative treatment (2008) (0)
Lung cancer risk prediction models for Mexican Americans and African Americans (2007) (0)
Willingness to provide biologic samples: results from a healthy urban population of Mexicans and Mexican-Americans in Texas (2003) (0)
Mutagen sensitivity predicts poor overall and disease specific survival in patients with stage III non-small cell lung cancer treated with chemo/radiotherapy (2004) (0)
ACase – Control Study of a Sex-Speci fi c Association between a 15 q 25 Variant and Lung Cancer Risk (2011) (0)
Statistical models for analysis of cytogenetic biomarkers. (2000) (0)
Erratum to: Assessing environmental and occupational risk factors for lung cancer in Mexican–Americans (2011) (0)
Whole Exome Sequencing Analysis Of Severe COPD (2017) (0)
COMMENT ON: MUTAGEN SENSITIVITY AS A RISK FACTOR FOR SECOND MALIGNANT TUMORS FOLLOWING MALIGNANCIES OF THE UPPER AERODIGESTIVE TRACT. AUTHORS' REPLY (1995) (0)
Cytokine gene polymorphisms and cancer-related symptoms in lung cancer patients (2007) (0)
Case control analysis of neuroblastoma and paternal occupation (1985) (0)
Abstract 1174: Genetic variations in microRNA biogenesis pathway genes as susceptibility loci for lung cancer risk (2011) (0)
Erratum to: Hierarchical modeling identifies novel lung cancer susceptibility variants in inflammation pathways among 10,140 cases and 11,012 controls (2016) (0)
Abstract 879: Mitochondrial DNA content and its association with lung cancer risk and clinical outcomes (2010) (0)
NNK-induced DNA damage as measured by the comet assay is a marker of lung cancer risk (2008) (0)
Agreement between child and mother ’ s self-reports and mother – mother self-reports on mother ’ s current smoking (0)
Lung and breast cancer death rates in Texas women. (1986) (0)
Associations between genetic polymorphisms and survival in patients with advanced non-small cell lung cancer (NSCLC) treated with paclitaxel-based therapy (2008) (0)
Association of genetic variations in DNA-methyltransferases, histone-methyltransferases, and methylated DNA-binding proteins with recurrence and survival in early-stage non-small cell lung cancer treated with surgery alone or surgery and chemotherapy. (2010) (0)
Abstract IA15: Role of environment in genetic predisposition: Lessons from tobacco studies (2020) (0)
BRCA2-branching out too? (2015) (0)
Abstract 889: An analysis of single nucleotide polymorphisms of 125 DNA repair genes in the Texas genome-wide association study of lung cancer with a replication for theXRCC4SNPs (2011) (0)
Lymphocyte mutagen sensitivity correlates significantly with gender, histology, and radiation toxicity in lung cancer patients (2000) (0)
Abstract A86: Psychosocial and genetic determinants of cigarette experimentation in Mexican heritage youth (2010) (0)
Abstract LB-334: Functional polymorphisms in the stem-cell related pathway affect susceptibility to non-small cell lung cancer: a finding from Texas lung cancer genome-wide association study (2012) (0)
Abstract LB-441: The genome wide gene-environment interaction analysis for asbestos exposure on lung cancer susceptibility (2011) (0)
Smoking Susceptibility in Mexican Origin Youth: Family and Community Factors (2006) (0)
Fluorescent in situ hybridization analysis in blood lymphocytes of lung cancer patients. (1996) (0)
The authors reply. (2015) (0)
Association between Family History Sensitivity in Upper Aerodigestive (1993) (0)
Germline Predictors of Outcome in Non-small Cell Lung Cancer (2007) (0)

This paper list is powered by the following services:

What Schools Are Affiliated With Margaret R. Spitz?

Margaret R. Spitz is affiliated with the following schools:

Margaret R. Spitz's Academic­Influence.com Rankings

Margaret R. Spitz's Degrees

Why Is Margaret R. Spitz Influential?

Margaret R. Spitz's Published Works

Published Works

What Schools Are Affiliated With Margaret R. Spitz?

Margaret R. Spitz's AcademicInfluence.com Rankings